Pulmatrix (PULM) Equity Average (2016 - 2025)
Pulmatrix (PULM) has disclosed Equity Average for 12 consecutive years, with $4.3 million as the latest value for Q4 2025.
- Quarterly Equity Average fell 57.0% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, down 57.0% year-over-year, with the annual reading at $6.4 million for FY2025, 52.65% down from the prior year.
- Equity Average hit $4.3 million in Q4 2025 for Pulmatrix, down from $5.2 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $54.9 million in Q2 2021 to a low of $4.3 million in Q4 2025.
- Historically, Equity Average has averaged $26.1 million across 5 years, with a median of $23.4 million in 2023.
- Biggest five-year swings in Equity Average: skyrocketed 427.06% in 2021 and later tumbled 60.56% in 2025.
- Year by year, Equity Average stood at $46.3 million in 2021, then dropped by 28.59% to $33.1 million in 2022, then crashed by 42.75% to $18.9 million in 2023, then plummeted by 47.55% to $9.9 million in 2024, then plummeted by 57.0% to $4.3 million in 2025.
- Business Quant data shows Equity Average for PULM at $4.3 million in Q4 2025, $5.2 million in Q3 2025, and $6.4 million in Q2 2025.